Tad Cautious On Ancom, But Positive On Long Term

ANCOMNY’s 2HFY24 performance will continue to be weighed  down by weak industrial chemical margins, though partially cushioned by strong agri-chemical off-takes underpinned by its existing offerings and there is room for sales to improve for its newer products.

Kenanga Investment Bank’s (Kananga) Company Update today (Apr 4 ) said they cut their FY24F net profit forecast by 11% but maintained their TP of RM1.50 and OUTPERFORM call.

The house came away from a recent engagement with ANCOMNY feeling a tad cautious on its near-term outlook but remaining positive on its long-term  prospects. The key takeaways are as follows:

1. A less toxic alternative to Paraquat, MSMA Latin and North  American sales are helping to offset softer Thai demand where current dry weather has reduced farmers’ need to apply MSMA. More importantly, Brailizian usage of MSMA extending  beyond sugarcane to include soyabean is progressing well with possible contribution from FY25 onwards. Indonesia has also  approved an MSMA-variant but it is a new MSMA market and  Paraquat is still allowed in Indonesia, so meaningful contributions will take time to emerge. 

2. Robust timber preservative offtake. Talks with a longstanding  US buyer for a sizeable supply contract are now in advanced stages. The agreement is for (i) a 3-year period, with (ii) quarterly  price reviews and will comprise half the group’s future timber  preservative sales. Meanwhile, pending the contract signing,  orders are constantly being refreshed.

3. Newer agri-chemicals Bromacil and Ester sales are slower  than expected. Targeted at the pineapple and cereal markets,  demand is decent but overall contribution is small. Recent selling  prices are also under some pressures, hence ANCOMNY is  emphasising more on other new active ingredients until Bromacil  and Ester markets become more active.

4. Latest agri-chemical addition, active ingredient no. 7 or AI  “T”, should start selling soon after a half-year delay. However,  to improve stability and consistency, ANCOMNY is adding another  manufacturing step into the process. Stable-state  commercialisation may thus be delayed by 6-12 months as  additional equipment should be installed in June followed by fine tuning. Till then, inputs will be purchased as originally planned. 

5. Industrial chemical cost base undergoing reviews. As  earnings are largely derived from trading, margins are thinner. To  improve margins, ANCOMNY is gradually relocating its southern  peninsular storage facility in Singapore to Johor where leases can  be 50-60% lower. The first phase of this 2-3 years relocation  undertaking will commence in 2QFY25. 

Forecasts. Kenanga cuts their FY24F net profit forecast by 11% on weaker than-expected industrial chemical margins.

Valuations. However, Kenanga maintained their TP of RM1.50 which is based on 13x FY25F PER, at about half the forward PER of larger regional  agriculture chemical peers. There is no adjustment to their TP based on  ESG given a 3-star rating as appraised by them.

Investment case. Kenanga continues to like ANCOMNY for: (i) its position as the largest herbicide active ingredients producer in  South-East Asia, (ii) a beneficiary of the widening ban on Paraquat use, (iii) a beneficiary of US-China trade tension as well  as (iv) being a proxy to global food production and food security goal. Kenanga maintains Outperform. 

Risks to Kenanga’s call include: (i) downturn in key crop markets, (ii) regulatory risk, and (iii) foreign exchange translation.

Previous article5G Monetisation, Dual Network Unveiling In 2Q May Support ARPU
Next articleTaiwan Earthquake Injuries Climb Above 1,000, Hotel Workers Still Missing

LEAVE A REPLY

Please enter your comment!
Please enter your name here